Mangoceuticals, Inc. Common Stock (MGRX) — Strategic Asset Allocation Index
Mangoceuticals, Inc. Common Stock (MGRX) has a Strategic Asset Allocation Index of 7.2% as of March 2023. Strategic assets (PP&E of $275.85K plus long-term investments of $-) total $275.85K, measured against net assets of $3.82 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Mangoceuticals, Inc. Common Stock (MGRX) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Mangoceuticals, Inc. Common Stock Strategic Asset Allocation Index (2022–2022)
This chart shows how Mangoceuticals, Inc. Common Stock's Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of March 2023, the index stands at 7.2%, representing strategic assets of $275.85K against net assets of $3.82 Million USD. For live market cap and overall valuation, see Mangoceuticals, Inc. Common Stock market capitalisation.
Annual Strategic Asset Allocation Index for Mangoceuticals, Inc. Common Stock (2022–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Mangoceuticals, Inc. Common Stock from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Mangoceuticals, Inc. Common Stock net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 47.5% | $291.74K | $291.74K | $- | $614.03K | — |